Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Naive T cell deficits at diagnosis and after chemotherapy impair cell therapy potential in pediatric cancers.

Das RK, Vernau L, Grupp SA, Barrett DM.

Cancer Discov. 2019 Jan 10. pii: CD-18-1314. doi: 10.1158/2159-8290.CD-18-1314. [Epub ahead of print]

PMID:
30630850
2.

Nasal obstruction symptom evaluation score outcomes after septorhinoplasty.

Gerecci D, Casanueva FJ, Mace JC, Annen A, Barrett DM, Kim MM, Wang TD, Smith TL, Loyo M.

Laryngoscope. 2018 Dec 21. doi: 10.1002/lary.27578. [Epub ahead of print]

PMID:
30575041
3.

A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release.

Xu Y, Yang Z, Horan LH, Zhang P, Liu L, Zimdahl B, Green S, Lu J, Morales JF, Barrett DM, Grupp SA, Chan VW, Liu H, Liu C.

Cell Discov. 2018 Nov 20;4:62. doi: 10.1038/s41421-018-0066-6. eCollection 2018.

4.

CD3+/CD19+ Depleted Matched and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplant with Targeted T Cell Addback Is Associated with Excellent Outcomes in Pediatric Patients with Nonmalignant Hematologic Disorders.

Oved JH, Wang Y, Barrett DM, Levy EM, Huang Y, Monos DS, Grupp SA, Bunin NJ, Olson TS.

Biol Blood Marrow Transplant. 2018 Oct 9. pii: S1083-8791(18)30612-8. doi: 10.1016/j.bbmt.2018.10.003. [Epub ahead of print]

PMID:
30312755
5.

Getting the most from your CAR target.

Barrett DM.

Blood. 2018 Oct 4;132(14):1467-1468. doi: 10.1182/blood-2018-08-869552. No abstract available.

PMID:
30287468
6.

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell.

Ruella M, Xu J, Barrett DM, Fraietta JA, Reich TJ, Ambrose DE, Klichinsky M, Shestova O, Patel PR, Kulikovskaya I, Nazimuddin F, Bhoj VG, Orlando EJ, Fry TJ, Bitter H, Maude SL, Levine BL, Nobles CL, Bushman FD, Young RM, Scholler J, Gill SI, June CH, Grupp SA, Lacey SF, Melenhorst JJ.

Nat Med. 2018 Oct;24(10):1499-1503. doi: 10.1038/s41591-018-0201-9. Epub 2018 Oct 1.

PMID:
30275568
7.

Neurotoxicity after CTL019 in a pediatric and young adult cohort.

Gofshteyn JS, Shaw PA, Teachey DT, Grupp SA, Maude S, Banwell B, Chen F, Lacey SF, Melenhorst JJ, Edmonson MJ, Panzer J, Barrett DM, McGuire JL.

Ann Neurol. 2018 Oct;84(4):537-546. doi: 10.1002/ana.25315. Epub 2018 Sep 26.

PMID:
30178481
8.

CD19 alterations emerging after CD19-directed immunotherapy cause retention of the misfolded protein in the endoplasmic reticulum.

Bagashev A, Sotillo E, Tang CA, Black KL, Perazzelli J, Seeholzer SH, Argon Y, Barrett DM, Grupp SA, Hu CA, Thomas-Tikhonenko A.

Mol Cell Biol. 2018 Aug 13. pii: MCB.00383-18. doi: 10.1128/MCB.00383-18. [Epub ahead of print]

9.

Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells.

Ghassemi S, Nunez-Cruz S, O'Connor RS, Fraietta JA, Patel PR, Scholler J, Barrett DM, Lundh SM, Davis MM, Bedoya F, Zhang C, Leferovich J, Lacey SF, Levine BL, Grupp SA, June CH, Melenhorst JJ, Milone MC.

Cancer Immunol Res. 2018 Sep;6(9):1100-1109. doi: 10.1158/2326-6066.CIR-17-0405. Epub 2018 Jul 20.

PMID:
30030295
10.

Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response.

Foster JB, Choudhari N, Perazzelli J, Storm J, Hofmann TJ, Jain P, Storm PB, Pardi N, Weissman D, Waanders AJ, Grupp SA, Karikó K, Resnick AC, Barrett DM.

Hum Gene Ther. 2019 Feb;30(2):168-178. doi: 10.1089/hum.2018.145. Epub 2018 Oct 2.

PMID:
30024272
11.

Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia.

Bride KL, Vincent TL, Im SY, Aplenc R, Barrett DM, Carroll WL, Carson R, Dai Y, Devidas M, Dunsmore KP, Fuller T, Glisovic-Aplenc T, Horton TM, Hunger SP, Loh ML, Maude SL, Raetz EA, Winter SS, Grupp SA, Hermiston ML, Wood BL, Teachey DT.

Blood. 2018 Mar 1;131(9):995-999. doi: 10.1182/blood-2017-07-794214. Epub 2018 Jan 5.

PMID:
29305553
12.

Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemia.

Jo S, Lee JH, Mattei JJ, Barrett DM, van den Elzen P, Grupp SA, Reid GSD, Seif AE.

Leukemia. 2018 Feb;32(2):574. doi: 10.1038/leu.2017.312. Epub 2018 Jan 5.

PMID:
29303505
13.

High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model.

Richman SA, Nunez-Cruz S, Moghimi B, Li LZ, Gershenson ZT, Mourelatos Z, Barrett DM, Grupp SA, Milone MC.

Cancer Immunol Res. 2018 Jan;6(1):36-46. doi: 10.1158/2326-6066.CIR-17-0211. Epub 2017 Nov 27.

14.

Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemia.

Jo S, Lee JH, Mattei JJ, Barrett DM, van den Elzen P, Grupp SA, Reid GSD, Seif AE.

Leukemia. 2018 Feb;32(2):539-542. doi: 10.1038/leu.2017.290. Epub 2017 Sep 19. No abstract available. Erratum in: Leukemia. 2018 Jan 05;:.

PMID:
28924244
15.

Monocyte lineage-derived IL-6 does not affect chimeric antigen receptor T-cell function.

Singh N, Hofmann TJ, Gershenson Z, Levine BL, Grupp SA, Teachey DT, Barrett DM.

Cytotherapy. 2017 Jul;19(7):867-880. doi: 10.1016/j.jcyt.2017.04.001. Epub 2017 May 11.

PMID:
28506444
16.

Understanding Approaches to the Dorsal Hump.

Barrett DM, Casanueva F, Wang T.

Facial Plast Surg. 2017 Apr;33(2):125-132. doi: 10.1055/s-0037-1598033. Epub 2017 Apr 7.

PMID:
28388791
17.

Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia.

Fitzgerald JC, Weiss SL, Maude SL, Barrett DM, Lacey SF, Melenhorst JJ, Shaw P, Berg RA, June CH, Porter DL, Frey NV, Grupp SA, Teachey DT.

Crit Care Med. 2017 Feb;45(2):e124-e131. doi: 10.1097/CCM.0000000000002053.

18.

Effects of Peach Cultivar on Enzymatic Browning Following Cell Damage from High-Pressure Processing.

Techakanon C, Gradziel TM, Barrett DM.

J Agric Food Chem. 2016 Oct 12;64(40):7606-7614. Epub 2016 Sep 27.

PMID:
27626457
19.

Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies.

Ruella M, Barrett DM, Kenderian SS, Shestova O, Hofmann TJ, Perazzelli J, Klichinsky M, Aikawa V, Nazimuddin F, Kozlowski M, Scholler J, Lacey SF, Melenhorst JJ, Morrissette JJ, Christian DA, Hunter CA, Kalos M, Porter DL, June CH, Grupp SA, Gill S.

J Clin Invest. 2016 Oct 3;126(10):3814-3826. doi: 10.1172/JCI87366. Epub 2016 Aug 29.

20.

The Impact of Maturity Stage on Cell Membrane Integrity and Enzymatic Browning Reactions in High Pressure Processed Peaches (Prunus persica).

Techakanon C, Gradziel TM, Zhang L, Barrett DM.

J Agric Food Chem. 2016 Sep 28;64(38):7216-24. doi: 10.1021/acs.jafc.6b02252. Epub 2016 Sep 13.

PMID:
27556337
21.

Facelift Controversies.

Barrett DM, Gerecci D, Wang TD.

Facial Plast Surg Clin North Am. 2016 Aug;24(3):357-66. doi: 10.1016/j.fsc.2016.03.012. Epub 2016 Jun 10. Review.

PMID:
27400849
22.

Management of the Nasal Valve.

Barrett DM, Casanueva FJ, Cook TA.

Facial Plast Surg Clin North Am. 2016 Aug;24(3):219-34. doi: 10.1016/j.fsc.2016.03.001. Epub 2016 May 24. Review.

PMID:
27400837
23.

Dorsal Augmentation-Choosing the Right Material for the Right Patient.

Barrett DM, Wang TD.

JAMA Facial Plast Surg. 2016 Sep 1;18(5):333-4. doi: 10.1001/jamafacial.2016.0326. No abstract available.

PMID:
27258926
24.

Improved anti-leukemia activities of adoptively transferred T cells expressing bispecific T-cell engager in mice.

Liu X, Barrett DM, Jiang S, Fang C, Kalos M, Grupp SA, June CH, Zhao Y.

Blood Cancer J. 2016 Jun 3;6(6):e430. doi: 10.1038/bcj.2016.38.

25.

Inhibition of precursor B-cell malignancy progression by toll-like receptor ligand-induced immune responses.

Fidanza M, Seif AE, DeMicco A, Rolf N, Jo S, Yin B, Li Y, Barrett DM, Duque-Afonso J, Cleary ML, Bassing CH, Grupp SA, Reid GS.

Leukemia. 2016 Oct;30(10):2116-2119. doi: 10.1038/leu.2016.152. Epub 2016 May 25. No abstract available.

26.

The Beginning of the End of Package Deal Therapy for Patients With High-Risk Neuroblastoma?

Barrett DM, Bagatell R.

J Clin Oncol. 2016 Jul 20;34(21):2437-9. doi: 10.1200/JCO.2016.67.2774. Epub 2016 May 9. No abstract available.

PMID:
27161969
27.

Correlation of Descriptive Analysis and Instrumental Puncture Testing of Watermelon Cultivars.

Shiu JW, Slaughter DC, Boyden LE, Barrett DM.

J Food Sci. 2016 Jun;81(6):S1506-14. doi: 10.1111/1750-3841.13316. Epub 2016 Apr 22.

PMID:
27105291
28.

High hydrostatic pressure as a method to preserve fresh-cut Hachiya persimmons: A structural approach.

Vázquez-Gutiérrez JL, Quiles A, Vonasek E, Jernstedt JA, Hernando I, Nitin N, Barrett DM.

Food Sci Technol Int. 2016 Dec;22(8):688-698. Epub 2016 Apr 18.

PMID:
27091148
29.

Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia.

Teachey DT, Lacey SF, Shaw PA, Melenhorst JJ, Maude SL, Frey N, Pequignot E, Gonzalez VE, Chen F, Finklestein J, Barrett DM, Weiss SL, Fitzgerald JC, Berg RA, Aplenc R, Callahan C, Rheingold SR, Zheng Z, Rose-John S, White JC, Nazimuddin F, Wertheim G, Levine BL, June CH, Porter DL, Grupp SA.

Cancer Discov. 2016 Jun;6(6):664-79. doi: 10.1158/2159-8290.CD-16-0040. Epub 2016 Apr 13.

30.

T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastoma.

Singh N, Kulikovskaya I, Barrett DM, Binder-Scholl G, Jakobsen B, Martinez D, Pawel B, June CH, Kalos MD, Grupp SA.

Oncoimmunology. 2015 Aug 12;5(1):e1040216. eCollection 2016.

31.

Evolution of the rhytidectomy.

Barrett DM, Casanueva FJ, Wang TD.

World J Otorhinolaryngol Head Neck Surg. 2016 Feb 4;2(1):38-44. doi: 10.1016/j.wjorl.2015.12.001. eCollection 2016 Mar. Review.

32.

Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia.

Fraietta JA, Beckwith KA, Patel PR, Ruella M, Zheng Z, Barrett DM, Lacey SF, Melenhorst JJ, McGettigan SE, Cook DR, Zhang C, Xu J, Do P, Hulitt J, Kudchodkar SB, Cogdill AP, Gill S, Porter DL, Woyach JA, Long M, Johnson AJ, Maddocks K, Muthusamy N, Levine BL, June CH, Byrd JC, Maus MV.

Blood. 2016 Mar 3;127(9):1117-27. doi: 10.1182/blood-2015-11-679134. Epub 2016 Jan 26.

33.

Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies.

Singh N, Perazzelli J, Grupp SA, Barrett DM.

Sci Transl Med. 2016 Jan 6;8(320):320ra3. doi: 10.1126/scitranslmed.aad5222.

PMID:
26738796
34.

Spatial variance of physicochemical properties within mangos and the effect of initial ripeness stage on the quality of fresh-cut mangos.

Ngamchuachit P, Mitcham EJ, Barrett DM.

J Sci Food Agric. 2016 Aug;96(10):3613-20. doi: 10.1002/jsfa.7597. Epub 2016 Feb 8.

PMID:
26699838
35.

Current status of chimeric antigen receptor therapy for haematological malignancies.

Maude S, Barrett DM.

Br J Haematol. 2016 Jan;172(1):11-22. doi: 10.1111/bjh.13792. Epub 2015 Nov 12. Review.

PMID:
26560054
36.

Thermal pasteurization of ready-to-eat foods and vegetables: Critical factors for process design and effects on quality.

Peng J, Tang J, Barrett DM, Sablani SS, Anderson N, Powers JR.

Crit Rev Food Sci Nutr. 2017 Sep 22;57(14):2970-2995. doi: 10.1080/10408398.2015.1082126. Review.

PMID:
26529500
37.

Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy.

Sotillo E, Barrett DM, Black KL, Bagashev A, Oldridge D, Wu G, Sussman R, Lanauze C, Ruella M, Gazzara MR, Martinez NM, Harrington CT, Chung EY, Perazzelli J, Hofmann TJ, Maude SL, Raman P, Barrera A, Gill S, Lacey SF, Melenhorst JJ, Allman D, Jacoby E, Fry T, Mackall C, Barash Y, Lynch KW, Maris JM, Grupp SA, Thomas-Tikhonenko A.

Cancer Discov. 2015 Dec;5(12):1282-95. doi: 10.1158/2159-8290.CD-15-1020. Epub 2015 Oct 29.

38.

Donor-derived CD19 chimeric antigen receptor T cells.

Singh N, Barrett DM.

Curr Opin Hematol. 2015 Nov;22(6):503-8. doi: 10.1097/MOH.0000000000000179. Review.

PMID:
26457962
39.

Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall Street.

Barrett DM, Grupp SA, June CH.

J Immunol. 2015 Aug 1;195(3):755-61. doi: 10.4049/jimmunol.1500751. Review.

40.

Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein.

Qin H, Cho M, Haso W, Zhang L, Tasian SK, Oo HZ, Negri GL, Lin Y, Zou J, Mallon BS, Maude S, Teachey DT, Barrett DM, Orentas RJ, Daugaard M, Sorensen PH, Grupp SA, Fry TJ.

Blood. 2015 Jul 30;126(5):629-39. doi: 10.1182/blood-2014-11-612903. Epub 2015 Jun 3.

41.

Roadblocks to success for RNA CARs in solid tumors.

Singh N, Barrett DM, Grupp SA.

Oncoimmunology. 2015 Jan 7;3(12):e962974. eCollection 2014 Dec.

42.

Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data.

Wright CF, Fitzgerald TW, Jones WD, Clayton S, McRae JF, van Kogelenberg M, King DA, Ambridge K, Barrett DM, Bayzetinova T, Bevan AP, Bragin E, Chatzimichali EA, Gribble S, Jones P, Krishnappa N, Mason LE, Miller R, Morley KI, Parthiban V, Prigmore E, Rajan D, Sifrim A, Swaminathan GJ, Tivey AR, Middleton A, Parker M, Carter NP, Barrett JC, Hurles ME, FitzPatrick DR, Firth HV; DDD study.

Lancet. 2015 Apr 4;385(9975):1305-14. doi: 10.1016/S0140-6736(14)61705-0. Epub 2014 Dec 17.

43.

Vitamin retention in eight fruits and vegetables: a comparison of refrigerated and frozen storage.

Bouzari A, Holstege D, Barrett DM.

J Agric Food Chem. 2015 Jan 28;63(3):957-62. doi: 10.1021/jf5058793. Epub 2015 Jan 13.

PMID:
25526594
44.

Mineral, fiber, and total phenolic retention in eight fruits and vegetables: a comparison of refrigerated and frozen storage.

Bouzari A, Holstege D, Barrett DM.

J Agric Food Chem. 2015 Jan 28;63(3):951-6. doi: 10.1021/jf504890k. Epub 2015 Jan 13.

PMID:
25525668
45.

The effects of bruising and temperature on enzyme activity and textural qualities of tomato juice.

Held MT, Anthon GE, Barrett DM.

J Sci Food Agric. 2015 Jun;95(8):1598-604. doi: 10.1002/jsfa.6990. Epub 2014 Dec 1.

PMID:
25377927
46.

Cost-based decision analysis of postreduction imaging in the management of mandibular fractures.

Barrett DM, Halbert TW, Fiorillo CE, Park SS, Christophel JJ.

JAMA Facial Plast Surg. 2015 Jan-Feb;17(1):28-32. doi: 10.1001/jamafacial.2014.782.

PMID:
25356588
47.

Effect of acidification on carrot (Daucus carota) juice cloud stability.

Schultz AK, Barrett DM, Dungan SR.

J Agric Food Chem. 2014 Nov 26;62(47):11528-35. doi: 10.1021/jf5042855. Epub 2014 Nov 17.

PMID:
25354298
48.

Chimeric antigen receptor T cells for sustained remissions in leukemia.

Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, Chew A, Gonzalez VE, Zheng Z, Lacey SF, Mahnke YD, Melenhorst JJ, Rheingold SR, Shen A, Teachey DT, Levine BL, June CH, Porter DL, Grupp SA.

N Engl J Med. 2014 Oct 16;371(16):1507-17. doi: 10.1056/NEJMoa1407222. Erratum in: N Engl J Med. 2016 Mar 10;374(10):998.

49.

Nature of tumor control by permanently and transiently modified GD2 chimeric antigen receptor T cells in xenograft models of neuroblastoma.

Singh N, Liu X, Hulitt J, Jiang S, June CH, Grupp SA, Barrett DM, Zhao Y.

Cancer Immunol Res. 2014 Nov;2(11):1059-70. doi: 10.1158/2326-6066.CIR-14-0051. Epub 2014 Aug 7.

50.

Surgical perspectives in craniofacial trauma.

Schmitt PJ, Barrett DM, Christophel JJ, Leiva-Salinas C, Mukherjee S, Shaffrey ME.

Neuroimaging Clin N Am. 2014 Aug;24(3):531-52, viii-ix. doi: 10.1016/j.nic.2014.03.007. Epub 2014 May 21. Review.

PMID:
25086810

Supplemental Content

Loading ...
Support Center